A new series of TBB-derivatives was synthesized and characterized as CK2 inhibitors. Crystallographic analysis and docking studies were used to understand the mode of binding.
No takes yet. Share an insight, caveat, or question.
Świder et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: